[3582] Khan, U. A., Liu L., Provenzano F. A., Berman D. E., Profaci C. P., Sloan R., et al. (2014).  Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease. Nature Neuroscience. 17(2), 304 - 311.

[3586] Lambert, J-C., Ibrahim-Verbaas C. A., Harold D., Naj A. C., Sims R., Bellenguez C., et al. (2013).  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature Genetics. 45(12), 1452 - 1458.

[2997] Bateman, R. J., Xiong C., Benzinger T. L. S., Fagan A. M., Goate A., Fox N. C., et al. (2012).  Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease. New England Journal of Medicine. 120723122607004 - 120723122607004.

[2728] Cruchaga, C., Chakraverty S., Mayo K., Vallania F. L. M., Mitra R. D., Faber K., et al. (2012).  Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families. PLoS ONE. 7(2), e31039 - e31039.

[2257] Naj, A. C., Jun G., Beecham G. W., Wang L-S., Vardarajan B. N., Buros J., et al. (2011).  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 43(5), 436 - 441.

[830] Mayeux, R., Vannucci S. J., Small S. A., Wu W., Brickman A. M., Luchsinger J., et al. (2008).  The brain in the age of old: The hippocampal formation is targeted differentially by diseases of late life. Annals of Neurology. 64(6), 698 - 706.

[712] Reitz, C., Tang M-X., Manly J., Mayeux R., & Luchsinger J. A. (2007).  Hypertension and the Risk of Mild Cognitive Impairment. Arch Neurol. 64(12), 1734 - 1740.

[2405] Luchsinger, J. A., Tang M-X., Shea S., & Mayeux R. (2002).  Caloric Intake and the Risk of Alzheimer Disease. Arch Neurol. 59(8), 1258 - 1263.